- 2 سال پیش
- 139
- 05:52
7th Case: Thrombocytopenia
Daily cardiology
0
توضیحات
Any Concerns for OACs Use in Patients with Thrombocytopenia
Avatar
کاربر شنوتواولین نفر کامنت بزار
- 141
- 2 سال پیش
OAC of choice in patients with hepatic impairment, any difference between DOACs?...
OAC of choice in patients with hepatic impairment,...
05:38
- 141
- 2 سال پیش
05:38
- 150
- 2 سال پیش
Low dose Rivaroxaban in SIHD, COMPASS trial...
Low dose Rivaroxaban in SIHD, COMPASS trial
09:00
- 150
- 2 سال پیش
09:00
- 155
- 2 سال پیش
OAC choice in patients with obesity or low body weights, any role for DOACs?...
OAC choice in patients with obesity or low body we...
09:33
- 155
- 2 سال پیش
09:33
- 159
- 2 سال پیش
OAC of choice in patients with artificial heart valves...
OAC of choice in patients with artificial heart va...
11:30
- 159
- 2 سال پیش
11:30
- 149
- 2 سال پیش
Anticoagulation of choice in patients with cancer, the importance of DDI...
Anticoagulation of choice in patients with cancer,...
12:58
- 149
- 2 سال پیش
12:58
- 161
- 2 سال پیش
Antithrombotic regimen of choice in patients with AF undergoing elective PCI...
Antithrombotic regimen of choice in patients with ...
12:57
- 161
- 2 سال پیش
12:57
Endocrinologist Perspective on SGLT2 inhibitors...
Endocrinologist Perspective on SGLT2 inhibitors
26:51
- 164
- 2 سال پیش
26:51
Role of SGLT2 inhibitors in HF patients from two perspectives: Endocrinology & Cardiology...
Role of SGLT2 inhibitors in HF patients from two p...
09:36
- 152
- 2 سال پیش
09:36
- 197
- 2 سال پیش
Multidisciplinary approach to CVD Prevention...
Multidisciplinary approach to CVD Prevention
02:06:19
- 197
- 2 سال پیش
02:06:19
تمامی حقوق این وبسایت متعلق به شنوتو است